Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome
Background We aimed to describe the frequency and yield of genetic testing in supravalvar aortic stenosis (SVAS) following negative evaluation for Williams‐Beuren syndrome (WS). Methods and Results This retrospective cohort study included patients with SVAS at our institution who had a negative eval...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-04-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.034048 |
_version_ | 1797205519840051200 |
---|---|
author | Sara B. Stephens Tyler Novy Gabrielle N. Spurzem Benjamin Jacob Taylor Beecroft Emily Soludczyk Beth A. Kozel Justin Weigand Shaine A. Morris |
author_facet | Sara B. Stephens Tyler Novy Gabrielle N. Spurzem Benjamin Jacob Taylor Beecroft Emily Soludczyk Beth A. Kozel Justin Weigand Shaine A. Morris |
author_sort | Sara B. Stephens |
collection | DOAJ |
description | Background We aimed to describe the frequency and yield of genetic testing in supravalvar aortic stenosis (SVAS) following negative evaluation for Williams‐Beuren syndrome (WS). Methods and Results This retrospective cohort study included patients with SVAS at our institution who had a negative evaluation for WS from May 1991 to September 2021. SVAS was defined as (1) peak supravalvar velocity of ≥2 meters/second, (2) sinotubular junction or ascending aortic Z score <−2.0, or (3) sinotubular junction Z score <−1.5 with family history of SVAS. Patients with complex congenital heart disease, aortic valve disease as the primary condition, or only postoperative SVAS were excluded. Genetic testing and diagnoses were reported. Of 162 patients who were WS negative meeting inclusion criteria, 61 had genetic testing results available (38%). Chromosomal microarray had been performed in 44 of 61 and was nondiagnostic for non‐WS causes of SVAS. Sequencing of 1 or more genes was performed in 47 of 61. Of these, 39 of 47 underwent ELN sequencing, 20 of 39 (51%) of whom had a diagnostic variant. Other diagnoses made by gene sequencing were Noonan syndrome (3 PTPN11, 1 RIT1), Alagille syndrome (3 JAG1), neurofibromatosis (1 NF1), and homozygous familial hypercholesterolemia (1 LDLR1). Overall, sequencing was diagnostic in 29 of 47 (62%). Conclusions When WS is excluded, gene sequencing for SVAS is high yield, with the highest yield for the ELN gene. Therefore, we recommend gene sequencing using a multigene panel or exome analysis. Hypercholesterolemia can also be considered in individuals bearing the stigmata of this disease. |
first_indexed | 2024-04-24T08:52:25Z |
format | Article |
id | doaj.art-a6f4c9205229419ba3cbb1d911547173 |
institution | Directory Open Access Journal |
issn | 2047-9980 |
language | English |
last_indexed | 2024-04-24T08:52:25Z |
publishDate | 2024-04-01 |
publisher | Wiley |
record_format | Article |
series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
spelling | doaj.art-a6f4c9205229419ba3cbb1d9115471732024-04-16T09:33:09ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802024-04-0113810.1161/JAHA.123.034048Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams SyndromeSara B. Stephens0Tyler Novy1Gabrielle N. Spurzem2Benjamin Jacob3Taylor Beecroft4Emily Soludczyk5Beth A. Kozel6Justin Weigand7Shaine A. Morris8Section of Cardiology, Department of Pediatrics Baylor College of Medicine, Texas Children’s Hospital Houston TXDivision of Community and General Pediatrics, Department of Pediatrics, McGovern Medical School The University of Texas Health Science Center Houston TXUniversity of Washington Medical Center Seattle WASection of Cardiology, Department of Pediatrics Baylor College of Medicine, Texas Children’s Hospital Houston TXSection of Cardiology, Department of Pediatrics Baylor College of Medicine, Texas Children’s Hospital Houston TXSection of Cardiology, Department of Pediatrics Baylor College of Medicine, Texas Children’s Hospital Houston TXTranslational Vascular Medicine Branch National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda MDSection of Cardiology, Department of Pediatrics Baylor College of Medicine, Texas Children’s Hospital Houston TXSection of Cardiology, Department of Pediatrics Baylor College of Medicine, Texas Children’s Hospital Houston TXBackground We aimed to describe the frequency and yield of genetic testing in supravalvar aortic stenosis (SVAS) following negative evaluation for Williams‐Beuren syndrome (WS). Methods and Results This retrospective cohort study included patients with SVAS at our institution who had a negative evaluation for WS from May 1991 to September 2021. SVAS was defined as (1) peak supravalvar velocity of ≥2 meters/second, (2) sinotubular junction or ascending aortic Z score <−2.0, or (3) sinotubular junction Z score <−1.5 with family history of SVAS. Patients with complex congenital heart disease, aortic valve disease as the primary condition, or only postoperative SVAS were excluded. Genetic testing and diagnoses were reported. Of 162 patients who were WS negative meeting inclusion criteria, 61 had genetic testing results available (38%). Chromosomal microarray had been performed in 44 of 61 and was nondiagnostic for non‐WS causes of SVAS. Sequencing of 1 or more genes was performed in 47 of 61. Of these, 39 of 47 underwent ELN sequencing, 20 of 39 (51%) of whom had a diagnostic variant. Other diagnoses made by gene sequencing were Noonan syndrome (3 PTPN11, 1 RIT1), Alagille syndrome (3 JAG1), neurofibromatosis (1 NF1), and homozygous familial hypercholesterolemia (1 LDLR1). Overall, sequencing was diagnostic in 29 of 47 (62%). Conclusions When WS is excluded, gene sequencing for SVAS is high yield, with the highest yield for the ELN gene. Therefore, we recommend gene sequencing using a multigene panel or exome analysis. Hypercholesterolemia can also be considered in individuals bearing the stigmata of this disease.https://www.ahajournals.org/doi/10.1161/JAHA.123.034048cardiovasculargeneticsSVASWilliams syndrome |
spellingShingle | Sara B. Stephens Tyler Novy Gabrielle N. Spurzem Benjamin Jacob Taylor Beecroft Emily Soludczyk Beth A. Kozel Justin Weigand Shaine A. Morris Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease cardiovascular genetics SVAS Williams syndrome |
title | Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome |
title_full | Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome |
title_fullStr | Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome |
title_full_unstemmed | Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome |
title_short | Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome |
title_sort | genetic testing for supravalvar aortic stenosis what to do when it is not williams syndrome |
topic | cardiovascular genetics SVAS Williams syndrome |
url | https://www.ahajournals.org/doi/10.1161/JAHA.123.034048 |
work_keys_str_mv | AT sarabstephens genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT tylernovy genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT gabriellenspurzem genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT benjaminjacob genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT taylorbeecroft genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT emilysoludczyk genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT bethakozel genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT justinweigand genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome AT shaineamorris genetictestingforsupravalvaraorticstenosiswhattodowhenitisnotwilliamssyndrome |